Cytek Biosciences, Inc. (CTKB)

US — Healthcare Sector
Peers: HSKA  KIDS  ELMD  LUNG  RXST  AXGN  TMCI  OFIX  NPCE  INGN  SRDX  APYX  OSA  LIVN  SGHT  SSKN  VAPO  TLIS 

Automate Your Wheel Strategy on CTKB

With Tiblio's Option Bot, you can configure your own wheel strategy including CTKB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol CTKB
  • Rev/Share 1.5354
  • Book/Share 2.958
  • PB 1.1292
  • Debt/Equity 0.0196
  • CurrentRatio 5.6211
  • ROIC -0.0842

 

  • MktCap 423041060.0
  • FreeCF/Share 0.1366
  • PFCF 24.1241
  • PE -38.0958
  • Debt/Assets 0.0154
  • DivYield 0
  • ROE -0.029

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 3
  • P/B Score 3
  • D/E Score 4

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade CTKB TD Cowen Buy Hold -- $4 May 9, 2025
Downgrade CTKB Goldman Buy Sell $7 $4.5 Jan. 31, 2025

News

Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript
CTKB
Published: May 11, 2025 by: Seeking Alpha
Sentiment: Neutral

Cytek Biosciences, Inc. (NASDAQ:CTKB ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Paul Goodson - IR Wenbin Jiang - CEO William McCombe - CFO Conference Call Participants David Westenberg - Piper Sandler Chad Wiatrowski - TD Cowen Andrew Cooper - Raymond James Operator Thank you for standing by. At this time, I would like to welcome everyone to the Cytek Biosciences First Quarter 2025 Earnings Conference Call.

Read More
image for news Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript
Cytek Biosciences, Inc. (CTKB) Q4 2024 Earnings Conference Call Transcript
CTKB
Published: February 28, 2025 by: Seeking Alpha
Sentiment: Neutral

Cytek Biosciences, Inc. (NASDAQ:CTKB ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Paul Goodson - IR Wenbin Jiang - CEO William McCombe - CFO Conference Call Participants David Westenberg - Piper Sandler Matthew Sykes - Goldman Sachs Chad Wiatrowski - TD Cowen Harrison Parsons - Stephens Inc. Operator Thank you for standing by, and good day, everyone. My name is RG, and I will be your conference operator today.

Read More
image for news Cytek Biosciences, Inc. (CTKB) Q4 2024 Earnings Conference Call Transcript

About Cytek Biosciences, Inc. (CTKB)

  • IPO Date 2021-07-23
  • Website https://cytekbio.com
  • Industry Medical - Devices
  • CEO Dr. Wenbin Jiang Ph.D.
  • Employees 663
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.